【结 构 式】 |
【药物名称】Holmium-166-DOTMP , 166Ho-DOTMP 【化学名称】1,1',1'',1'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis(methylphosphonic acid) 166holmium complex 【CA登记号】 【 分 子 式 】C12H32HoN4O12P4 【 分 子 量 】714.30364 |
【开发单位】International Isotopes (Supplier), Aventis Pharma (Originator), NeoRx (Licensee) 【药理作用】Multiple Myeloma Therapy, Oncolytic Drugs, Radiation Therapy |
合成路线1
The reaction of 1,4,7,10-tetraazacyclododecane (I) with formaldehyde and phosphoric acid in refluxing aqueous HCl gives the tetraphosphonic acid (II), which is then treated with aqueous 166HoCl3 to obtain the target chelate.
【1】 Simon, J.; Garlich, J.R.; Wilson, D.A.; McMillan, K. (Marion Merrell Dow, Inc.); Bone marrow suppressing agents. EP 0374501; JP 1990237936; US 4882142 . |
Extended Information